CanSino Biologics Inc. (OTCMKTS:CASBF – Get Free Report) saw a large increase in short interest in May. As of May 29th, there was short interest totaling 1,000 shares, an increase of ∞ from the May 14th total of 0 shares. Based on an average daily trading volume, of 623 shares, the short-interest ratio is presently 1.6 days.
CanSino Biologics Price Performance
Shares of CASBF opened at C$3.10 on Friday. CanSino Biologics has a 1 year low of C$3.00 and a 1 year high of C$6.99. The stock has a 50 day simple moving average of C$3.69 and a two-hundred day simple moving average of C$4.15.
CanSino Biologics Company Profile
CanSino Biologics Inc is a China-based biopharmaceutical company focused on the research, development and commercialization of vaccine products. Headquartered in Tianjin, the company leverages an adenovirus vector platform to develop single-dose and recombinant vaccines targeting a range of infectious diseases. CanSino’s pipeline includes its authorized COVID-19 vaccine, Convidecia (Ad5-nCoV), as well as candidates for Ebola, influenza and other pathogens.
Since its founding in 2009, CanSino has built end-to-end capabilities spanning antigen discovery, process development and large-scale manufacturing.
Read More
- Five stocks we like better than CanSino Biologics
- Time to Sell? 3 Winners With Fading Technical Momentum
- Why These 2 Hotel Stocks Are Beating Travel Peers
- This Energy Stock Has Quietly Soared 130% in a Year
- 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups
Receive News & Ratings for CanSino Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CanSino Biologics and related companies with MarketBeat.com's FREE daily email newsletter.
